Repurposed drug for blood cancer patients


A drug commonly used to treat arthritis may help treat some blood cancers, a new UK study has found.


A collaboration between the universities of Sheffield, Oxford and Cambridge, had shown how methotrexate (MTX), a low-cost drug used for the treatment of a number of autoimmune diseases including rheumatoid arthritis, might have benefits for blood cancer patients with studies in fruit flies and mice.


The results of the study, which coincides with Blood Cancer Awareness Month, showed that blood cancer patients who were already taking MTX for another condition, exhibited fewer symptoms compared with patients who were not receiving the drug.


“Given the very low cost of MTX, this research could offer an effective therapy on a budget accessible to healthcare systems throughout the world,” said Dr Martin Zeidler, of the Department of Biomedical Science at the University of Sheffield.

Copyright © 2019 European Animal Research Association, All rights reserved.

European Animal Research Association 
 

London Office

Abbey House, 74-76 St John Street
London EC1M 4DZ
Tel: +44 (0)20 3675 1245
Email: info@eara.eu 

Brussels Office
52 Rue Marie de Bourgogne, 1st Floor
1000 Brussels,
Belgium

 

  • INSTAGRAM
  • Twitter
  • Facebook
  • LinkedIn Social Icon
  • INSTAGRAM
  • Facebook Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon